Series A financing

Shanghai, China, September 10, 2026 Solstice Oncology, a partner of Harbour BioMed, has announced a $225 million Series A...

Naarden, The Netherlands, August 19, 2026 Kynexis, a clinical-stage biotechnology company developing therapies for cognitive disorders, has raised an...

Worcester, Massachusetts, August 17, 2026 Leal Therapeutics, a clinical-stage biopharmaceutical company developing neuro-metabolic therapeutics for central nervous system disorders,...

SAN DIEGO, Calif., June 20, 2026 cAMPfield Therapeutics has officially emerged from stealth with a $180 million Series A...

SEATTLE, June 17, 2026 Vedana Therapeutics has officially emerged from stealth with $46 million in Series A financing to...

SPRING HOUSE, Pa., Feb. 4, 2026 — Clinical-stage biotechnology company Third Arc Bio announced the closing of a $52...

Boulder, Colorado, January 20, 2026 — Think Bioscience, a privately held biotechnology company focused on unlocking historically “undruggable” drug...